STK38L: A Potential Drug Target and Biomarker (G23012)

Target Name: STK38L

NCBI ID: G23012

STK38L

STK38L: A Potential Drug Target and Biomarker

Serine/threonine kinase 38 (STK38L) is a protein that plays a crucial role in cell signaling pathways. It is a key regulator of the protein serine/threonine kinase (PTK) signaling pathway, which is involved in cell growth, differentiation, and survival. The STK38L protein has been identified as a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

The STK38L protein is a member of the STK family of serine/threonine kinases, which are a group of non-protein kinases that regulate various cellular processes, including cell signaling pathways. The STK family includes several different proteins, including STK2, STK3, STK4, STK5, and STK6, which are involved in cell signaling pathways such as G1/S, G0/G1, and G1/S.

STK38L is a 12kDa protein that is expressed in various tissues and cells, including skeletal muscles, heart, brain, and pancreas. It is involved in the regulation of cellular processes such as cell growth, differentiation, and survival, and has been implicated in the development and progression of several diseases.

One of the key functions of STK38L is its role as a negative regulator of the PTK signaling pathway. The PTK signaling pathway is a critical pathway involved in the regulation of cellular processes such as cell growth, differentiation, and survival. It is a complex signaling pathway that involves the interaction of several different proteins, including STK38L.

STK38L functions as a negative regulator of the PTK signaling pathway by regulating the activity of the protein tyrosine phosphatase (TYP), which is a key enzyme involved in the regulation of PTK activity. TYP is a scaffold protein that plays a key role in the regulation of various cellular processes, including cell signaling pathways. It is involved in the regulation of several different proteins, including PTK, which is a critical enzyme involved in the regulation of cellular processes such as cell growth, differentiation, and survival.

STK38L has been shown to play a role in the regulation of cellular processes such as cell growth, differentiation, and survival. It has been shown to interact with several different proteins, including the protein tyrosine phosphatase (TYP), which is a key enzyme involved in the regulation of PTK activity. This interaction between STK38L and TYP suggests that STK38L may be a potential drug target for the treatment of diseases that are characterized by the over-activity of TYP.

In addition to its role as a negative regulator of the PTK signaling pathway, STK38L has also been shown to play a role in the regulation of cellular processes such as cell adhesion, migration, and invasion. It is involved in the regulation of several different proteins that are involved in these processes, including the protein vimentin, which is involved in cell adhesion and migration, and the protein cadherin, which is involved in cell-cell adhesion.

STK38L has also been shown to play a role in the regulation of cellular processes such as cell survival and angiogenesis. It is involved in the regulation of several different proteins that are involved in these processes, including the protein Bcl-2, which is involved in the regulation of cell survival, and the protein Fas, which is involved in the regulation of angiogenesis.

In conclusion, STK38L is a protein that plays a crucial role in cell signaling pathways, including the regulation of the PTK signaling pathway. It has been identified as a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Further research is needed to fully understand the role of STK38L in

Protein Name: Serine/threonine Kinase 38 Like

Functions: Involved in the regulation of structural processes in differentiating and mature neuronal cells

The "STK38L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about STK38L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets